The term “designated drug” means any negotiation-eligible drug (as defined in section 1192(d) of the Social Security Act) included on the list published under section 1192(a) of such Act which is manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing.
The term “United States” has the meaning given such term by section 4612(a)(4).
Rules similar to the rules of paragraphs (2) and (4) of section 4132(c) shall apply for purposes of this section.
Rules similar to the rules of section 4662(e) (other than section 4662(e)(2)(A)(ii)(II)) shall apply for purposes of this chapter.
The Secretary shall prescribe such regulations and other guidance as may be necessary to carry out this section.